1 Cash-Gushing Stock Down 70% to Buy and Hold Forever

Most stocks suffering a 70% decline in share price tend not to qualify as anything close to a cash cow capable of generating immense free cash flow (FCF). But Doximity (NYSE: DOCS), with its digital platform for healthcare professionals, is the exception to this theory, with a top-tier gross profit around 90% and FCF margins of 35%.

So, does the 70% decline in share price indicate there is something fundamentally wrong with the business, leaving this immense cash generation at risk? Or could this be an opportunity for patient investors?

Here's why I'm thinking it'd be the latter.

Continue reading


Source Fool.com